These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14973302)

  • 1. Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.
    Shi J; Montay G; Chapel S; Hardy P; Barrett JS; Sack M; Marbury T; Swan SK; Vargas R; Leclerc V; Leroy B; Bhargava VO
    J Clin Pharmacol; 2004 Mar; 44(3):234-44. PubMed ID: 14973302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the ketolide telithromycin after single and repeated doses in patients with hepatic impairment.
    Cantalloube C; Bhargava V; Sultan E; Vacheron F; Batista I; Montay G
    Int J Antimicrob Agents; 2003 Aug; 22(2):112-21. PubMed ID: 12927950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment.
    Shi J; Chapel S; Montay G; Hardy P; Barrett JS; Sica D; Swan SK; Noveck R; Leroy B; Bhargava VO
    Int J Clin Pharmacol Ther; 2005 Mar; 43(3):123-33. PubMed ID: 15792396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses.
    Namour F; Wessels DH; Pascual MH; Reynolds D; Sultan E; Lenfant B
    Antimicrob Agents Chemother; 2001 Jan; 45(1):170-5. PubMed ID: 11120961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and absolute oral bioavailability of an 800-mg oral dose of telithromycin in healthy young and elderly volunteers.
    Perret C; Lenfant B; Weinling E; Wessels DH; Scholtz HE; Montay G; Sultan E
    Chemotherapy; 2002 Dec; 48(5):217-23. PubMed ID: 12476037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of food on the bioavailability of a new ketolide antibacterial, telithromycin.
    Bhargava V; Lenfant B; Perret C; Pascual MH; Sultan E; Montay G
    Scand J Infect Dis; 2002; 34(11):823-6. PubMed ID: 12578152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telithromycin: the first ketolide antimicrobial.
    Nguyen M; Chung EP
    Clin Ther; 2005 Aug; 27(8):1144-63. PubMed ID: 16199242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial.
    Shi J; Montay G; Bhargava VO
    Clin Pharmacokinet; 2005; 44(9):915-34. PubMed ID: 16122280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections.
    Ciervo CA; Shi J
    Curr Med Res Opin; 2005 Oct; 21(10):1641-50. PubMed ID: 16238904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telithromycin.
    Wellington K; Noble S
    Drugs; 2004; 64(15):1683-94; discussion 1695-6. PubMed ID: 15257629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
    Sobue S; Tan K; Layton G; Leclerc V; Weil A
    Br J Clin Pharmacol; 2004 Jun; 57(6):773-84. PubMed ID: 15151523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora.
    Edlund C; Alván G; Barkholt L; Vacheron F; Nord CE
    J Antimicrob Chemother; 2000 Nov; 46(5):741-9. PubMed ID: 11062193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of itraconazole or grapefruit juice on the pharmacokinetics of telithromycin.
    Shi J; Montay G; Leroy B; Bhargava VO
    Pharmacotherapy; 2005 Jan; 25(1):42-51. PubMed ID: 15767219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).
    Muller-Serieys C; Soler P; Cantalloube C; Lemaitre F; Gia HP; Brunner F; Andremont A
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3104-8. PubMed ID: 11600363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of degree of hepatic or renal impairment on the pharmacokinetics of exemestane in postmenopausal women.
    Jannuzzo MG; Poggesi I; Spinelli R; Rocchetti M; Cicioni P; Buchan P
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):475-81. PubMed ID: 15014897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of telithromycin (HMR 3647), a new ketolide antimicrobial, into inflammatory blister fluid following oral administration.
    Namour F; Sultan E; Pascual MH; Lenfant B
    J Antimicrob Chemother; 2002 Jun; 49(6):1035-8. PubMed ID: 12039900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
    Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.